Role of immune checkpoint blockers in patients with EGFR mutation

Research output: Contribution to journal › Editorial

Original language	English
Pages (from-to)	S385-S387
Journal	Translational Lung Cancer Research
Volume	7
DOIs	https://doi.org/10.21037/TLCR.2018.09.13
State	Published - Dec 2018

Access to Document

@article{b1c61d259f134d1ba67437db0fbce0ee,

title = "Role of immune checkpoint blockers in patients with EGFR mutation",

author = "Jeffrey Ward and Daniel Morgensztern",

year = "2018",

month = dec,

doi = "10.21037/TLCR.2018.09.13",

language = "English",

volume = "7",

pages = "S385--S387",

journal = "Translational Lung Cancer Research",

issn = "2218-6751",

}

TY - JOUR

T1 - Role of immune checkpoint blockers in patients with EGFR mutation

AU - Ward, Jeffrey

AU - Morgensztern, Daniel

PY - 2018/12

Y1 - 2018/12

UR - http://www.scopus.com/inward/record.url?scp=85070568917&partnerID=8YFLogxK

U2 - 10.21037/TLCR.2018.09.13

DO - 10.21037/TLCR.2018.09.13

M3 - Editorial

AN - SCOPUS:85070568917

VL - 7

SP - S385-S387

JO - Translational Lung Cancer Research

JF - Translational Lung Cancer Research

SN - 2218-6751

ER -